ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, specializes in developing innovative medical devices and cloud-based software applications to manage respiratory disorders. With a market capitalization of $36.86 billion, ResMed operates both in the United States and internationally, focusing on two primary segments: Sleep and Breathing Health, and Residential Care Software. The company is well-positioned in the Medical Instruments & Supplies industry, delivering solutions that cater to sleep apnea and other respiratory ailments.

ResMed’s current stock price stands at $252.55, reflecting a minimal change of 0.03% amidst a 52-week range of $204.54 to $293.73. The forward price-to-earnings (P/E) ratio of 20.74…